A Prospective Longitudinal Study of Fecal Microbiome and Calprotectin to Predict Response to Biological Therapy in Patients With CD

NCT03994224 · clinicaltrials.gov ↗

TERMINATED

Status

13

Enrollment

OTHER

Sponsor class

Stopped Decision made by team of investigators

Conditions

Crohn Disease
Perianal Crohn Disease

Sponsor

Chinese University of Hong Kong